Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
Coccidioidomycosis, commonly known as Valley Fever, is an infectious disease caused by the soil-dwelling fungus Coccidioides immitis, which is primarily found in specific geographic regions such as Southern California, the Southwestern United States, Northwestern Mexico, and certain areas of Central and South America. The skin test for coccidioidomycosis is a diagnostic procedure designed to evaluate the cellular immune response of individuals who may have been exposed to this fungus. During the test, a small amount of the fungal antigen is introduced into the skin through a pinprick. This method allows healthcare providers to assess whether the immune system has previously encountered the fungus. A positive reaction at the test site may suggest either an active infection or a history of exposure to the fungus, indicating that the individual's immune system has responded to the antigen. The test is crucial for diagnosing coccidioidomycosis, especially in patients presenting with symptoms consistent with the disease, as it helps differentiate between active and past infections.
© Copyright 2026 Coding Ahead. All rights reserved.
The skin test for coccidioidomycosis is indicated for individuals who have had potential exposure to the Coccidioides fungus. The following conditions may warrant the performance of this test:
The procedure for conducting a skin test for coccidioidomycosis involves several key steps to ensure accurate results:
After the skin test for coccidioidomycosis is performed, patients are advised to keep the test site clean and dry. They should avoid scratching or irritating the area to prevent false results. The healthcare provider will schedule a follow-up appointment to evaluate the test results. If the test is positive, further diagnostic evaluation may be necessary to determine if there is an active infection or if the individual has a history of exposure. Patients should be informed about potential symptoms of coccidioidomycosis and advised to seek medical attention if they experience any concerning signs following the test.
| Short Descr | COCCIDIOIDOMYCOSIS SKIN TEST | Medium Descr | SKIN TEST COCCIDIOIDOMYCOSIS | Long Descr | Skin test; coccidioidomycosis | Status Code | Active Code | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 3 - Technical Component Only Code | Multiple Procedures (51) | 0 - No payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | STV-Packaged Codes | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1G - Lab tests - other (Medicare fee schedule) | MUE | Not applicable/unspecified. | CCS Clinical Classification | 235 - Other Laboratory |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2024-12-31 | Deleted | Code Deleted. |
| Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.